G’day and welcome to your weekly edition of Overnight Success - your download on all the important things that have happened in the Aussie startup ecosystem. 🚀
After a month of AI infrastructure dominating the news, the biggest cheque of the week went somewhere else entirely - BioTech! AdvanCell raised US$315 million to target alpha radiation at prostate cancer, and it looks like the largest private biotech raise this country has produced. Brandon Capital is on the register, two weeks after its Myricx windfall. Australian life sciences are having a moment! Well, till Albo gave a speech about AI for Australia, we were back to AI infrastructure dominating the news.
👀 Headlines 👀
🏛️ Prime Minister Anthony Albanese announced a new Office of AI, to sit inside the Department of the Prime Minister and Cabinet and coordinate AI standards across government. It’s pitched as a world-first attempt to bring economic, social, security and environmental AI issues under one roof.
Albo, in a speech titled “AI in Australia’s interests", spoke about copyright protection, data centres and the streamlining of developments. Here’s a summation of what he spoke about and is planning:
Copyright protection for creators: Australian writers, musicians, artists and journalists must retain ownership and control of their work, including pricing. Using it to train AI without consent is, in his words, theft.
Data centre obligations: large data centres must underwrite new power supply, pay full grid connection costs, be net energy generators (by mostly adding renewables), minimise water use, and pay for any water infrastructure — so costs don't fall on households.
Streamlined governance: a flexible framework rather than legislating every risk, designed to speed approvals and attract investment while maintaining community trust.
While acknowledging that the build-out of data centres and net power generation requirements feels like common sense policy for Australia, there was little acknowledgement of anyone building on top of this infrastructure stack. Australia has real potential to contribute to the full stack of AI. Our startups and scale-ups are building foundational models, and we have AI native companies growing rapidly in market-leading ways.
⁉ Apparently, Treasury or the government didn’t do any modelling before the federal budget on how capital gains tax reforms would affect startups, in the latest sign that the federal government rushed the sweeping changes. (Innovation Aus)
The May budget scrapped the longstanding 50% CGT discount in favour of an inflation-linked rate and a 30% minimum tax, sparking warnings from founders that startups would be pushed offshore and investment would dry up.
😡 Australia's startup sector has united to reject the government's CGT olive branch, the Innovative Business CGT Concession (IBCC), proposed in response to backlash against the broader capital gains overhaul. (Capital Brief)
Initially welcomed as "constructive", the Tech Council has since joined the robotics, Fintech, AgriTech, EduTech, MedTech, and BioTech groups to lobby against the plan, writing to Chalmers to demand higher age and turnover ceilings and the grandfathering of pre-reform investments.
In submissions to Treasury, the Tech Council of Australia, FinTech Australia, Aussie Angels, AusBiotech, Startmate and others called it "woefully inadequate" and an "administrative nightmare," warning the $10M lifetime cap, $50M turnover threshold, 10-year company age limit and five-year holding period would push founders offshore.
🏗 Construction has begun on Australia’s first commercial semiconductor packaging facility in Western Sydney, one of only ~12 such facilities worldwide, giving the country a rare foothold in the global chip supply chain when it opens in late 2027. (Innovation Aus)
Housed in the second building of NSW's Advanced Manufacturing Readiness Facility, the plant will develop next-gen tech like fan-out wafer-level packaging and 2.5D architecture, with breakthroughs tipped in fields like quantum computing.
NSW has tipped a combined $300 million into the two AMRF buildings, hoping to draw semiconductor, advanced manufacturing, defence and robotics firms to Bradfield City and the Aerotropolis.
The build is more than a year behind schedule on some estimates, following delays caused by a dispute with the Electrical Trades Union. The second is being delivered by Hansen Yuncken.
🏆 Canva co-founder Melanie Perkins launched the Global Goals Platform, a global initiative that asks communities a single question — "What is one goal you would like to see achieved in your lifetime?" — and publishes where the answers overlap, applying the user-feedback machinery that helps prioritise product feedback at Canva. (The Age, Melanie Perkins’ LinkedIn Post)
The first pilot kicks off in Wollongong from July 24, inviting the city's 220,000+ residents to submit what they want for their community in a partnership with Wollongong City Council. A second US pilot with the Ad Council follows, both feeding a report due late this year.
The platform builds on the Canva Foundation's work in Malawi, where 130,000+ people have received unconditional cash transfers of ~US$550 each via GiveDirectly, funded by US$50 million since 2021, with Canva saying 90% of those reached now live above the extreme poverty line.
📊 Australian tech raised US$1.9 billion in H1 2026, with late-stage capital doubling down even as exits stalled, according to Tracxn's Australia Tech Semi-Annual Funding Report.
Australia Tech raised $1.9B in H1 2026, up 19% on H2 2025 and 64% on H1 2025, but the rebound was almost entirely late-stage. Late-stage funding hit $1.4B (up 40%), while seed funding fell 37% to $57.2M. Capital is consolidating around fewer, larger, later bets.
Five $100M+ rounds closed (vs three in H2 2025), led by Firmus ($505M Series F, backed by Nvidia and Coatue) and Airwallex ($320M Series H at an $11B valuation), with Synthetix, Gilmour Space and Advanced Navigation all clearing $110M. Round count actually dropped to 63 from 80.
🔄 Onto Ventures, the Byron Bay climate and regenerative tech firm founded by Dan Fitzgerald in 2020, has rebranded from ReGen Ventures.
🏅 Australia's sportstech sector hit $7.11B in revenue in FY2026, with growth accelerating to 16%, up from 10% in each of the prior two years. Employment grew 6% to 20,604 people across 924 companies nationwide, according to ASTN's fifth annual Sports Innovation Report.
The top 115 companies, which make up ~12% of the sector, generate 89% of revenue (A$6.30B) and 74% of employment. Category leaders like Catapult Sports, PMY Group, Bodd, VALD and Champion Data are driving the numbers, while the overall company count grew just 1.8%.
South-East Queensland is forecast to overtake NSW in both business numbers and employment by FY2028, powered by investment ahead of Brisbane 2032. Victoria (38%) still leads, with Melbourne alone accounting for 39% of sector revenue.
More than one in four sportstech businesses now serve adjacent markets like health, defence, events, media, and education. Women founders, though, slipped to 8% (from 9%).
The enterprise deal is ready. Is your SOC 2?
The fastest-growing startups get compliant early.
That's where Vanta comes in. Used by over 16,000 companies like Ramp, Cursor, and Harvey, Vanta helps you get audit-ready quickly — and stay that way.
Don't let compliance be the reason a deal slips. Sign up with Vanta today, and get $1,000 off.
⚡ Startup Retro ⚡
AdvanCell closes a US$315 million Series D for targeted radiation therapy to fight tumours
CEO: Philina Lee
AdvanCell, a Brisbane-based clinical-stage radiopharmaceutical company developing targeted alpha therapies for cancer, has closed an oversubscribed and upsized US$315 million (about A$452 million) Series D. Based on the available numbers, it is the largest fundraising ever completed by a private Australian biotech.
Ally Bridge Group led the round, with Alpha Wave co-leading. The round also included Bain Capital Life Sciences, Fidelity Management & Research Company, funds and accounts advised by T. Rowe Price Associates, an unnamed sovereign wealth fund, Eventide Asset Management and Velosity Capital. Existing backers Morningside, Eli Lilly and Company, SV Health Investors, Sanofi Ventures, Abingworth, SymBiosis, Tenmile, Brandon Capital, Piper Heartland, Catalio Capital Management, Proto Axiom and Time BioVentures also came along. Andrew Lam of Ally Bridge and Nik Economopoulos of Alpha Wave join the board.
AdvanCell's platform is built around proprietary Lead-212 technology, and the program ADVC001 is a Lead-212 PSMA-targeted alpha therapy for metastatic prostate cancer, currently in Phase 2 (NCT05720130). The pitch for alpha therapy is precision: it can deliver potent alpha radiation to tumour cells while sparing healthy tissue, addressing the resistance and tolerability limits that dog existing PSMA radioligand treatments. The company says Phase 1b showed encouraging anti-tumour activity and favourable tolerability. This round takes ADVC001 toward registrational Phase 3.
Targeted alpha therapy has been held back less by chemistry than by supply chain, because the isotopes are hard to source and harder to manufacture at scale. AdvanCell's answer was to own the whole chain: isotope supply, automated manufacturing, and vertically integrated, scalable production.
AdvanCell now describes itself as operating out of Boston and Brisbane, with sites in Sydney, Brisbane, Adelaide and Boston, and the proceeds are explicitly earmarked for expanding US isotope supply and manufacturing. There is also an IRS Form 8937 on the company's investor page referencing a redomiciliation.
Due Diligence: AdvanCell announcement, Forbes Australia, FierceBiotech, FinSMEs
ESGAgent secures a Seed round for an AI-compliance platform for heavy industry
Founder: Shan Vahora
ESGAgent.ai, the Brisbane sustainability, safety and compliance platform for heavy industry, has closed a seed round led by US-Japan firm DNX Ventures, pushing total funding to $1.7 million. This is the second Australian investment DNX has made following the Zeligate seed round in November 2025.
As mandatory climate disclosures, modern slavery rules, and new biodiversity obligations grow, heavy industry is drowning in spreadsheets, consultants and disconnected systems. ESGAgent.ai's AI-native platform consolidates those workflows, claiming to compress reporting timelines "from months to hours." Its customer roster already includes tier-one miners, major food manufacturers, global engineering consultants, and the Queensland Government, Lite n’Easy, Forest One, and XENCO.
The journey begins when the user uploads their existing resources, policies, emissions data, safety records and prior reports into a centralised knowledge library that the platform reads and organises against the frameworks that matter to them, whether that's AASB S2, TCFD, GRI, SASB, CDP or an industry-specific standard.
From there, the AI does the heavy lifting: it assesses the material, flags gaps, and generates comprehensive, framework-aligned reports in minutes, sparing the user the tedium of manually cross-referencing overlapping regulations.
The user simply converses with a dedicated AI agent in plain language, by voice or even image, and gets instant, sourced guidance. Once the initial reporting is done, the platform shifts into continuous monitoring mode, scanning documents in real time and pushing actionable alerts the moment a compliance gap or new exposure emerges. The net effect is that the user spends far less time hunting for information and formatting disclosures, and far more time acting on risks—turning compliance from a reactive, resource-draining chore into a proactive, strategic function they can manage from a single system.
The company is also beefing up its bench, adding former Arcadis commercial chief Greg Steele as investor and director, and ex-Ashurst risk advisory head Mike Duggan as EGM. The fresh capital will fund product development and customer acquisition as ESGAgent.ai pursues its goal of becoming the default system of record for Australian compliance.
Due Diligence: Business News Australia, Startup Daily
BlueNexus lands $2M to help experts build AI agents
Founders: Chris Were, Nick Arbuckle and Aurélien Ticot
Most people with specific expertise may find building sophisticated AI agents challenging. BlueNexus wants to change that and has raised $2.0M (US$1.3 million) to try. The Sydney startup's seed round was led by M31 Capital, with Antler, Eastend Ventures, and inSilico One joining.
BlueNexus is building an "agent management platform" that lets anyone go from idea to a working, revenue-generating AI agent in about the time it takes to drink a coffee.
Agent builders describe the agent you want in plain language, and BlueNexus drafts its skills, personality and data connections in about 20 minutes—or you grab a pre-built one from its marketplace. From there, the platform runs the whole lifecycle. Agents plug into 100+ native connectors across CRMs, dev tools and wearables via a single MCP endpoint, build a persistent knowledge base with cited sources, execute tasks on a schedule, and produce versioned, editable Pages.
The target users are domain experts, lawyers, coaches, accountants, clinicians, who package and monetise their know-how, plus product teams embedding agents in weeks rather than quarters. For regulated sectors, confidential compute is an optional add-on.
Founded in 2025 by Chris Were, Nick Arbuckle and Aurélien Ticot, BlueNexus will spend the cash on rollout, its connector ecosystem, and SOC 2 compliance.
Due Diligence: Business News Australia, Startup Daily
Hyades secures $910k pre-seed for hyperspectral foundational model
Founders: Ashin Alex, Sam Kurian and Jimin Seo
Insurers, miners, and farmers are sitting on mountains of map-based data made up of satellite imagery, drone footage, and radar data. But almost none of it is in a format that AI can use. The Auckland Spatial AI lab Hyades reckons it can fix that, and has raised a NZ$1.1 million (A$910k) pre-seed round.
The round was led by Icehouse Ventures, with backing from K1W1 and angel investors Tony Falkenstein and Tim Brown. Hyades also secured an NZ$400,000 government "New to R&D" grant.
The platform, called HyperPrism, is still in early alpha and aims to fuse fragmented, messy spatial data into a single, AI-ready format for industries such as insurance, agriculture, mining, and climate science. The flagship use case is risk modelling. Today, an insurer wanting to gauge future flood exposure must do the slow grind of manually collating imagery, flood records and other data. Hyades automates it, letting them quickly build models showing which properties face the greatest risk of flooding, cyclones, or wildfires.
Their other product, BlazerOps, allows users to build partial machine learning pipelines and optimised architectures for individual companies.
Founded by University of Auckland grads Alex, Sam Kurian, and Jimin Seo, Hyades will spend the cash on enterprise co-design partners, AI engineering hires, and scaling toward a wider release.
Due Diligence: Spatial Source
Syngenis Lab raises $4M Pre-IPO round for RNA & DNA platform
Founders: Professor Rakesh Veedu
Australia produces world-class medical research but has long struggled to turn it into commercial medicines without shipping discoveries offshore. Perth biotech Syngenis Labs wants to keep drug discovery and commercialisation under one roof and has raised an oversubscribed $4 million pre-float round to do so.
Rather than betting on a single drug, Syngenis is building an integrated platform to take RNA and DNA-based medicines from concept to clinical-grade manufacturing under one roof. The rise, run through Euroz Hartleys, lands as global demand for RNA therapeutics and specialist manufacturing continues to climb in mRNA's post-COVID wake.
At the core is Discovery AI, a proprietary engine that identifies therapeutic targets, designs RNA and DNA candidates, screens them computationally and preps them for lab validation. It's already designed its first therapeutic candidate. A second AI engine, still in development, aims to simulate clinical trials before patients are enrolled, thereby reducing risk and costs.
The largest share of funding goes to a GMP manufacturing facility that is due to open in January, which would put Syngenis among a handful of labs worldwide able to make human-grade oligonucleotides for trials.
Due Diligence: The SMH
🚀 Wins 🚀
💰 NSW awarded over $1M across 22 startups in the latest MVP Ventures round, with grants from $24k to $75k, with 322 applications. (Innovation Aus)
Around half the funding went to women-owned, Aboriginal and Torres Strait Islander-owned, and regional NSW businesses.
The funded companies span modular housing, AI software for builders, electric jet ski conversion kits, flood monitoring, EV charger calibration and biopsy-free skin cancer diagnostics. (SmartCompany, NSW Government)
Funded companies include
Aquacultr Group landed a grant to commercialise its BioUltrasonics technology, a non-invasive ultrasound that reduces stress and improves welfare in farmed fish.
14modular was backed to scale its modular housing platform, using lean manufacturing and industrialised construction to build homes faster and cheaper.
DermR Health secured funding to advance its DermR® Patch, a microneedle-based molecular diagnostic technology for a less invasive way to test for skin cancer.
EClass Outboards secured support for its electric retrofit kit, which converts petrol jet skis into zero-emission marine transport.
📆 Notice Board 📆
🎵 BIGSOUND and CAST (Centre for Arts, Sports & Technology) are back for year two of their Startup Showcase at BIGSOUND 2026, hunting for companies building across creator tools, live events, fan engagement and the infrastructure supporting artists and venues.
Open to music-tech startups worldwide. Shortlisted teams pitch live at BIGSOUND. The selection committee includes TEN13 partner Sophie Robertson, Comes With Fries founder Vanessa Picken (now at TEG), and Mindset Music Tech's Drew Thurlow. Applications close 24 July, apply here.
🤝 In Great Company, a conversation series hosted by a friend of the newsletter, Jess Walker, kicks off its event series on 28 July with a founder breakfast featuring Alexey Mitko, who was Canva employee 23, the operator who scaled Koala from $10M to $100M, and co-founder of the recently $1.6B-acquired Eucalyptus.
The breakfast is on Monday, 28 July, from 7:30 am–9:30 am at the Pillars, Sydney CBD, with a light breakfast provided. The content is for seed-to-scaleup founders and investors. Register here.
🍸 OS is teaming up with the Currents team for Bistro X, a curated Melbourne afternoon for founders, investors, and operators to network, not pitch!
It runs in the afternoon at The StandardX, 62 Rose St, Fitzroy, from 2:00 pm–5:00 pm. Tickets are $25, including a shared tab. Register here.
📣 Edition opened its 2026 Female Founder Grant: A$15,000 in brand, product strategy, market research, and pitch support for one woman building a high-growth tech company in Australia or New Zealand. Applications close 27 July.
🌱 South Australian founders with a product in market and early traction have a new path to investment readiness. ThincSeed is a 13-week program built for ventures that already have a working product, real customers or users, and early traction.
Selected founders work with facilitators, mentors and investors to strengthen commercial foundations and prepare for future fundraising conversations. Applications close Friday, 7 August 2026, 11:59 pm Adelaide time. 👉 Apply here
🧠 KaaS (Knowledge as a Service)
Will’s Pick: The “river of returns” by the Innovation Periodic Table
This is one of the coolest visualisations in the startup space. The visualisation shows how companies progress from incubation to the early stages, the bottlenecks they hit and the drastic drop off or lack of graduation. Finally, we see 1.3% of seed-funded companies become unicorns.
Have we missed something? Got some feedback? We love emails, so send one over!
👔 Connect with me on LinkedIn: Overnight Success, Will Richards
📈 Want to invest in great startups? Join Australia’s friendliest investment syndicate here, where small cheques are welcome!
Want better startup data? Check out our startup deals database, used by VCs, founders, and business development teams to stay on top of all high-signal data.
🚀 Want to get your product or offering in front of ~5,200 founders, investors and operators building scaling startups? Email us to learn more about our sponsorship and partnership opportunities.
❤ Getting a bunch of value from OS and want to support our growth? Consider becoming an OS Superhero.
‘Til next time,
👋 Will